Impax Heads To Rare Trial In Pay-For-Delay Case

Law360 (March 9, 2018, 10:04 PM EST) -- Impax Laboratories Inc. is set to face a Massachusetts jury Monday over allegations it received illegal reverse payments from Medicis Pharmaceutical Corp. to delay a generic form of acne medication Solodyn, one of just a handful of pay-for-delay cases to approach a verdict since the Supreme Court’s landmark Actavis ruling in 2013.

Here, Law360 breaks down what’s at stake in the case and why attorneys are watching.

Why Few Pay-For-Delay Cases Make It to Trial

Pay-for-delay litigation has largely hinged on the high court’s decision in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.